IDH1 AND IDH2 GENE MUTATIONS IDENTIFY NOVEL MOLECULAR SUBSETS WITHIN DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA (CN-AML): A CANCER AND LEUKEMIA GROUP B (CALGB) STUDY

被引：0
|
作者：
Marcucci, G. [1 ]
Maharry, K. [1 ]
Wu, Y. Z. [1 ]
Radmacher, M. [1 ]
Mrozek, K. [1 ]
Margeson, D. [1 ]
Holland, K. [1 ]
Whitman, S. [1 ]
Becker, H. [1 ]
Schwind, S. [1 ]
Metzeler, K. [1 ]
Powell, B. [2 ]
Carter, T. [3 ]
Kolitz, J. [4 ]
Wetzler, M. [5 ]
Baer, M. [6 ]
Carroll, A. [7 ]
Caligiuri, M. [1 ]
Larson, R. [8 ]
Bloomfield, C. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA
[3] Univ Iowa, Iowa City, IA USA
[4] N Shore Univ Hosp, Manhasset, NY USA
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Univ Maryland, Baltimore, MD 21201 USA
[7] Univ Alabama Birmingham, Birmingham, AL USA
[8] Univ Chicago, Chicago, IL 60637 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1107
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [21] Prevalence and clinical impact of IDH1 and IDH2 mutations among cytogenetically normal Egyptian acute myeloid leukaemia patients
    Aref, S. E.
    Kamel, E.
    Abou el Naga, A.
    Mohamed, O. A.
    Sabry, M. A.
    Al Biomy, M. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 85 - 85
  • [22] Wilms tumor 1 (WT1) gene mutations predict poor outcome in adults with cytogenetically normal (CN) acute myeloid leukemia (AML): A cancer and leukemia group B (CALGB) study
    Paschka, Peter
    Marcucci, Guido
    Ruppert, Amy S.
    Mrozek, Krzysztof
    Whitman, Susan P.
    Maharry, Kati
    Langer, Christian
    Baldus, Claudia D.
    Powell, Bayard L.
    Baer, Maria R.
    Carroll, Andrew J.
    Caligiuri, Michael A.
    Kolitz, Jonathan E.
    Larson, Richard A.
    Bloomfield, Clara D.
    BLOOD, 2007, 110 (11) : 113A - 114A
  • [23] Differential Clinical Impact Of Gene Mutations and Their Combinations In Primary Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
    Papaioannou, Dimitrios
    Maharry, Kati
    Mrozek, Krzysztof
    Becker, Heiko
    Metzeler, Klaus H.
    Mendler, Jason H.
    Whitman, Susan P.
    Eisfeld, Ann-Kathrin
    Schwind, Sebastian
    Wu, Yue-Zhong
    Nicolet, Deedra
    Kolitz, Jonathan E.
    Baer, Maria R.
    Powell, Bayard L.
    Bucci, Donna
    Caligiuri, Michael A.
    Carroll, Andrew J.
    Volinia, Stefano
    Stone, Richard M.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2013, 122 (21)
  • [24] Distinct Gene Expression Profiles and Mutations Associate with Outcome in Younger Adults with De Novo Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) (Alliance)
    Walker, Christopher J.
    Eisfeld, Ann-Kathrin
    Ozer, Hatice G.
    Kohlschmidt, Jessica
    Nicolet, Deedra
    Mrozek, Krzysztof
    Papaioannou, Dimitrios
    Genutis, Luke K.
    Powell, Bayard L.
    Uy, Geoffrey L.
    Kolitz, Jonathan E.
    Carroll, Andrew J.
    Stone, Richard
    Garzon, Ramiro
    Byrd, John C.
    de la Chapelle, Albert
    Bloomfield, Clara D.
    BLOOD, 2019, 134
  • [25] ACQUIRED MUTATIONS IN THE GENES ENCODING IDH1 AND IDH2 BOTH ARE RECURRENT ABERRATIONS IN ACUTE MYELOID LEUKEMIA (AML): PREVALENCE AND PROGNOSTIC VALUE
    Abbas, S.
    Lugthart, S.
    Kavelaars, F.
    Schelen, A.
    Koenders, J.
    Zeilemakers, A.
    van Putten, W.
    Rijneveld, A.
    Lowenberg, B.
    Valk, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 455 - 455
  • [26] Prognostic impact of NPM1 mutations in cytogenetically normal (CN) acute myeloid leukemia (AML) is adversely affected by high expression of the ERG gene:: A cancer and leukemia group B (CALGB) study
    Paschka, P.
    Marcucci, G.
    Maharry, K.
    Whitman, S. P.
    Ruppert, A. S.
    Vukosavljevic, T.
    Mrozek, K.
    Powell, B. L.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 145
  • [27] IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
    Petrova, Lucie
    Vrbacky, Filip
    Lanska, Miriam
    Zavrelova, Alzbeta
    Zak, Pavel
    Hrochova, Katerina
    CLINICAL BIOCHEMISTRY, 2018, 61 : 34 - 39
  • [28] PROGNOSTIC IMPACT OF ISOCITRATE DEHYDROGENASE ENZYME ISOFORMS 1 (IDH1) AND 2 (IDH2) MUTATIONS IN ACUTE MYELOID LEUKEMIA. A STUDY BY THE ACUTE LEUKEMIA FRENCH ASSOCIATION (ALFA) GROUP
    Nibourel, O.
    Boissel, N.
    Renneville, A.
    Gardin, C.
    Reman, O.
    Contentin, N.
    Bordessoule, D.
    Pautas, C.
    Revel, T.
    Quesnel, B.
    Philippe, N.
    Geffroy, S.
    Huchette, P.
    Terre, C.
    Thomas, X.
    Castaigne, S.
    Dombret, H.
    Preudhomme, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 455 - 455
  • [29] Prevalence and Clinical Effect of TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
    Markus, Birgit
    Thol, Felicitas
    Morgan, Michael A.
    Wagner, Katharina
    Heuser, Michael
    Krauter, Juergen
    Ganser, Arnold
    Damm, Frederik
    BLOOD, 2011, 118 (21) : 629 - 629
  • [30] HIF1a Expression Is Associated with NPM1 Mutation, but Not IDH1 or IDH2 Mutations in Acute Myeloid Leukemia with Normal Karyotype
    Hu, S.
    Ruvolo, V.
    Lu, H.
    Kantarjian, H. M.
    Wheeler, D.
    Muzny, D. M.
    Medeiros, L. J.
    Bueso-Ramos, C.
    Konopleva, M.
    Andreeff, M.
    Konoplev, S.
    LABORATORY INVESTIGATION, 2012, 92 : 342A - 342A
12345